These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 30878503)

  • 1. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment.
    Loera-Valencia R; Goikolea J; Parrado-Fernandez C; Merino-Serrais P; Maioli S
    J Steroid Biochem Mol Biol; 2019 Jun; 190():104-114. PubMed ID: 30878503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
    Lütjohann D; von Bergmann K
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxysterols and Alzheimer's disease.
    Björkhem I; Heverin M; Leoni V; Meaney S; Diczfalusy U
    Acta Neurol Scand Suppl; 2006; 185():43-9. PubMed ID: 16866910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Levels of 27-Hydroxycholesterol Induced by Dietary Cholesterol in Brain Contribute to Learning and Memory Impairment in Rats.
    Zhang X; Lv C; An Y; Liu Q; Rong H; Tao L; Wang Y; Wang Y; Xiao R
    Mol Nutr Food Res; 2018 Feb; 62(3):. PubMed ID: 29193679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
    Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
    Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammation.
    Testa G; Staurenghi E; Zerbinati C; Gargiulo S; Iuliano L; Giaccone G; Fantò F; Poli G; Leonarduzzi G; Gamba P
    Redox Biol; 2016 Dec; 10():24-33. PubMed ID: 27687218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of cholesterol hydroxylases in Alzheimer's disease.
    Brown J; Theisler C; Silberman S; Magnuson D; Gottardi-Littell N; Lee JM; Yager D; Crowley J; Sambamurti K; Rahman MM; Reiss AB; Eckman CB; Wolozin B
    J Biol Chem; 2004 Aug; 279(33):34674-81. PubMed ID: 15148325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease.
    Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ
    Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.
    Lukiw WJ
    Expert Rev Neurother; 2006 May; 6(5):683-93. PubMed ID: 16734516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins: drugs for Alzheimer's disease?
    Eckert GP; Wood WG; Müller WE
    J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol and apolipoprotein E in Alzheimer's disease.
    Reiss AB
    Am J Alzheimers Dis Other Demen; 2005; 20(2):91-6. PubMed ID: 15844755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma 24S hydroxycholesterol response to statins in Alzheimer's disease patients: effects of gender, CYP46, and ApoE polymorphisms.
    Vega GL; Weiner MF
    J Mol Neurosci; 2007 Sep; 33(1):51-5. PubMed ID: 17901546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The link between altered cholesterol metabolism and Alzheimer's disease.
    Gamba P; Testa G; Sottero B; Gargiulo S; Poli G; Leonarduzzi G
    Ann N Y Acad Sci; 2012 Jul; 1259():54-64. PubMed ID: 22758637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease.
    Gosselet F; Saint-Pol J; Fenart L
    Biochem Biophys Res Commun; 2014 Apr; 446(3):687-91. PubMed ID: 24275140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?
    Marwarha G; Ghribi O
    Exp Gerontol; 2015 Aug; 68():13-8. PubMed ID: 25261765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
    Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
    Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease.
    Wolozin B; Brown J; Theisler C; Silberman S
    CNS Drug Rev; 2004; 10(2):127-46. PubMed ID: 15179443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 24S-hydroxycholesterol in Alzheimer's disease.
    Kölsch H; Lütjohann D; von Bergmann K; Heun R
    J Nutr Health Aging; 2003; 7(1):37-41. PubMed ID: 12679839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.